Search Result for "%2A%3A%2A"
Story
Heidi Ko, MD, joins our breast oncology team as an assistant professor focusing on breast medical oncology. Dr. Ko received her medical degree from Rowan University School of Osteopathic Medicine in Stratford, New Jersey. She completed her residency in internal medicine at McGovern Medical School at The University of Texas Health Science Center at Houston. […]
Story
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – The cardio-oncology program at The University of Texas Health Science Center at San Antonio has been recognized by the International Cardio-Oncology Society as a Center of Excellence, reflecting its exceptionally high level of expertise in cardiovascular care of cancer patients and survivors. Cardio-oncology is a quickly developing […]
Story
Advancing the Science of Cancer in Latinos event set for Feb. 23-25 Media contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu On-site contact: Cliff Despres, (210) 562-6517, despres@uthscsa.edu Written by Cliff Despres, Institute for Health Promotion Research, UT Health San Antonio SAN ANTONIO — With one in three Latinos facing a cancer diagnosis in their lifetime, UT […]
Story
First lady Jill Biden toured Mays Cancer Center at UT Health San Antonio and praised its efforts in addressing disparities in cancer rates among Latinos.
Story
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – First lady Jill Biden toured Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), and praised its efforts in addressing disparities in cancer rates among Latinos. The visit came on the same day as the opening of the […]
Story
The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib to treat the chronic leukemia known as myelofibrosis. The FDA granted accelerated approval of the […]
Story
An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]
Story
Structural racism, rather than disease, leads to inequities, authors write Contacts: Will Sansom, (210) 567-2579, sansom@uthscsa.edu Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO (March 28, 2022) — Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of […]
Story
The UT Health San Antonio School of Dentistry has partnered with The Oral Cancer Foundation to host The San Antonio Oral Cancer Walk on Saturday, April 23, in observance of the 22nd Annual Oral Cancer Awareness Month.
Story
Lindsay Fry is a breast cancer survivor who was first diagnosed in 2019. Her treatment regimen of surgery, radiation and chemotherapy began in fall 2019. Shortly after completing her treatment, Fry became the first participant in a new clinical trial at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) that aims to help breast cancer survivors regain their energy and remain cancer free.